-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Initiates Coverage On InflaRx with Outperform Rating, Announces Price Target of $6

Benzinga·05/08/2025 14:15:34
Listen to the news
Oppenheimer analyst Andreas Argyrides initiates coverage on InflaRx (NASDAQ:IFRX) with a Outperform rating and announces Price Target of $6.